Myriad Genetics | MYGN - Себестоимость





Себестоимость Изменить Дата
Agilent USD 845M 7M 2026-03
Becton, Dickinson and Co. USD 2.67B 108M 2026-06
Bio-Rad Laboratories USD 305.2M 22.5M 2026-06
Bruker USD 422.5M 21.1M 2026-06
Danaher USD 2.65B 294M 2026-06
Illumina USD 389M 19M 2026-06
J&J USD 8B 67M 2026-06
Mettler Toledo International USD 396.52M 14.4M 2026-06
Myriad Genetics USD 63M 1.1M 2025-12
OraSure Technologies USD 15.43M 113K 2025-12
Pacific Biosciences Of California USD 28.9M 10M 2025-12
Quest Diagnostics USD 2.05B 64M 2026-06
Quidel USD 407M 486.5M 2026-06
Repligen USD 94.09M 8.12M 2026-06
Revvity USD 312.82M 10.64M 2026-06
Standard Biotools USD 9.84M 2.58M 2026-03
Thermo Fisher Scientific USD 7.54B 577M 2026-06
Veracyte USD 42.19M 3.7M 2026-06
Waters USD 1.16B 430M 2026-06